subject: UNII:94325AJ25N

subject_name: RINTATOLIMOD


subject: UNII:94325AJ25N

object_name: exocrine pancreatic carcinoma

tested_intervention: unsure


subject: UNII:94325AJ25N

object_name: malignant pancreatic neoplasm


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: Adult Solid Neoplasm


subject: CHEBI:44423

subject_name: Hydroxyurea


subject: MESH:C000629782

subject_name: talimogene laherparepvec

object_name: Childhood Breast Carcinoma


subject: MESH:C000629782

object_name: breast carcinoma


subject: MESH:C000629782

object_name: breast cancer


subject: UNII:07730V90L6

subject_name: Talimogene laherparepvec


subject: UNII:07730V90L6


subject: UNII:07730V90L6


subject: UMLS:C4282329

subject_name: Prostvac-V

object_name: prostate neoplasm

tested_intervention: yes


subject: MESH:D056692

subject_name: Prebiotics

object_name: obesity due to melanocortin 4 receptor deficiency


subject: MESH:D056692

object_name: obesity


subject: MESH:D056692

object_name: Obesity, CTCAE


subject: MESH:D056692

object_name: Weight loss


subject: MESH:D056692

object_name: Weight Loss, CTCAE


subject: UMLS:C4725096

subject_name: Androgen Receptor Antagonist BAY 1161116

object_name: Androgen excess


subject: CHEBI:167309

subject_name: Methadone

object_name: female reproductive organ cancer


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Out-of-Hospital Cardiac Arrest


subject: CHEBI:28918

object_name: ventricular fibrillation


subject: CHEBI:28918

object_name: Ventricular Fibrillation by ECG Finding


subject: CHEBI:28918

object_name: continuous electrocardiogram ventricular fibrillation


subject: CHEBI:28918

object_name: Ventricular Fibrillation, CTCAE 3.0


subject: CHEBI:28918

object_name: Ventricular Fibrillation, CTCAE 5.0


subject: CHEBI:28918

object_name: Pulseless ventricular tachycardia


subject: CHEBI:28918

object_name: cardiac conduction defect


subject: CHEBI:28918

object_name: sudden cardiac arrest


subject: CHEBI:28918

object_name: Aborted sudden cardiac death


subject: UNII:VKU5X213Q7

object_name: non-small cell lung carcinoma


subject: CHEBI:15365

subject_name: Aspirin

object_name: nicotine dependence


subject: GTOPDB:13710

subject_name: pelacarsen

object_name: atherosclerosis


subject: DRUGBANK:DB16284

subject_name: Pelacarsen


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: Too early


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:132922

object_name: Infection


subject: CHEBI:132922

object_name: infectious disease


subject: CHEBI:132922

object_name: Adverse Event Associated with Infection


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: hemolytic-uremic syndrome


subject: UNII:4F4X42SYQ6

object_name: Hemolytic Uremic Syndrome, CTCAE


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus

object_name: pancreatic adenocarcinoma


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: bipolar disorder


subject: CHEBI:4466

object_name: Schizophrenia agitation


subject: CHEBI:4466

object_name: schizoaffective disorder


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:95016

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:27300

subject_name: Ergocalciferol

object_name: hereditary hemorrhagic telangiectasia


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:60799

subject_name: Esketamine

object_name: Psychiatric comorbidities


subject: CHEBI:60799

object_name: Apathy


subject: CHEBI:60799

object_name: On examination - apathetic


subject: CHEBI:60799

object_name: Anhedonia


subject: CHEBI:60799

object_name: anxiety


subject: CHEBI:60799

object_name: anxiety disorder


subject: CHEBI:60799

object_name: Anxiety symptoms


subject: CHEBI:60799

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:60799

object_name: Anxiety, CTCAE 5.0


subject: UMLS:C5557658

subject_name: CPO 100

object_name: Childhood Solid Neoplasm


subject: UMLS:C5557658

object_name: Adult Solid Neoplasm


subject: UMLS:C5557658

object_name: Solid Neoplasm


subject: UNII:83G67E21XI

subject_name: Urokinase

object_name: end stage renal failure


subject: UNII:83G67E21XI

object_name: Chronic uremia


subject: UMLS:C0701941

subject_name: Abbokinase


subject: UMLS:C0701941


subject: UMLS:C1699394

subject_name: Hylenex

object_name: type 1 diabetes mellitus 1


subject: UMLS:C1699394

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid

object_name: esophageal cancer


subject: PUBCHEM.COMPOUND:135402009

object_name: Childhood Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:135402009

object_name: neoplasm of esophagus


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:63606


subject: CHEBI:4856

subject_name: Esmolol

object_name: myocardial ischemia


subject: CHEBI:4856

object_name: coronary atherosclerosis


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:6904


subject: UNII:HM5641GA6F

subject_name: Oprelvekin

object_name: hereditary von Willebrand disease


subject: UNII:HM5641GA6F

object_name: von Willebrand disease (hereditary or acquired)


subject: PR:000001366


subject: PR:000001366


subject: UMLS:C0537668

subject_name: Neumega


subject: UMLS:C0537668


subject: GTOPDB:4976


subject: GTOPDB:4976


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: hemophilia A


subject: CHEBI:89324

object_name: hemophilia B


subject: CHEBI:89324

object_name: hemophilia B leyden


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: MESH:D002136

subject_name: Calcium, Dietary


subject: MESH:D002136


subject: MESH:D002136


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UMLS:C3540037


subject: UMLS:C3540037


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: UNII:WY779SQ0XW


subject: UNII:WY779SQ0XW


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:29108


subject: CHEBI:29108


subject: CHEBI:22984

subject_name: Calcium


subject: CHEBI:22984


subject: CHEBI:22984


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C2936886


subject: UMLS:C2936886


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UMLS:C3714611


subject: UMLS:C3714611


subject: PUBCHEM.COMPOUND:18375622

subject_name: MART-1 Antigen

object_name: Stage IIC Cutaneous Melanoma AJCC v6 and v7


subject: PUBCHEM.COMPOUND:18375622

object_name: Stage IIA Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C3146272

subject_name: MART-1 Antigen (vaccine component)


subject: UMLS:C3146272


subject: UMLS:C1522481


subject: UMLS:C1522481


subject: UMLS:C4722543

subject_name: Toll-like Receptor 4 Agonist GLA-SE

object_name: stage IIIB melanoma


subject: UMLS:C4722543

object_name: stage IIIC melanoma


subject: UMLS:C4722543

object_name: stage IIIA melanoma


subject: UMLS:C4722543

object_name: stage IIC melanoma


subject: UMLS:C4722543


subject: UMLS:C4722543

object_name: stage IIA melanoma


subject: UMLS:C4722543


subject: UMLS:C4722543

object_name: stage IIB melanoma


subject: MESH:C513826

subject_name: Xue-Fu-Zhu-Yu decoction

object_name: angina unstable


subject: CHEBI:7852

subject_name: Oxycodone

object_name: Hypoventilation


subject: CHEBI:7852

object_name: Hypercapnia


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:7936

subject_name: Paroxetine


subject: CHEBI:7936


subject: CHEBI:7514

subject_name: Neostigmine

object_name: thyroid disease


subject: CHEBI:7514

object_name: Injuries, Surgical


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: small cell carcinoma


subject: CHEBI:177512

subject_name: Sagopilone


subject: UMLS:C2930786


subject: CHEBI:15365

subject_name: Aspirin

object_name: non-small cell lung carcinoma


subject: CHEBI:15365

object_name: EGFR gene mutation


subject: CHEBI:27300

subject_name: Ergocalciferol

object_name: hypogonadism


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: cytokine release syndrome


subject: CHEBI:60648

object_name: Cytokine storm


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: PUBCHEM.COMPOUND:54671203


subject: UNII:1O8VSL798T

subject_name: Talsaclidine

object_name: Alzheimer disease type 1


subject: UNII:1O8VSL798T

object_name: Alzheimer disease


subject: MESH:C000632565

subject_name: symtuza

object_name: HIV-1 infection


subject: MESH:C521519

subject_name: MVAp53 vaccine

object_name: Recurrent Platinum-Resistant Primary Peritoneal Carcinoma


subject: MESH:C521519

object_name: Recurrent Platinum-Resistant Fallopian Tube Carcinoma


subject: MESH:C521519

object_name: Recurrent Platinum-Resistant Ovarian Carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: arteriosclerosis disorder


subject: CHEBI:45863

object_name: atherosclerosis


subject: CHEBI:45863

object_name: peripheral arterial disease


subject: UNII:H8MTN7XVC2

subject_name: Mitometh

object_name: nasopharyngeal neoplasm


subject: PR:000029794

subject_name: mitochondrial import inner membrane translocase subunit Tim8 A


subject: CHEBI:94534

subject_name: olanzapine

object_name: mental disorder


subject: CHEBI:94534

object_name: psychiatric disorder


subject: CHEBI:8871

subject_name: Risperidone


subject: CHEBI:8871


subject: CHEBI:188074

object_name: pituitary tumor


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: PUBCHEM.COMPOUND:135449332

subject_name: Eltrombopag

object_name: Diamond-Blackfan anemia


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: Bone fracture


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: UNII:T1NAO7YDA7

subject_name: VEREKITUG

object_name: Severe asthma


subject: UMLS:C5909037

subject_name: Verekitug


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Induced vaginal delivery


subject: CHEBI:63610

subject_name: Misoprostol


subject: PUBCHEM.COMPOUND:3367

object_name: skin neoplasm


subject: PUBCHEM.COMPOUND:3367

object_name: skin cancer


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]

object_name: venous thromboembolism


subject: UMLS:C2825026

object_name: thrombophilia due to thrombin defect


subject: UMLS:C2825026

object_name: Hemorrhage


subject: UMLS:C2825026

object_name: myocardial infarction


subject: UMLS:C2825026

object_name: Myocardial Infarction, CTCAE


subject: UMLS:C2825026

object_name: Myocardial Infarction by ECG Finding


subject: UMLS:C3485429

subject_name: Probiotic Formula

object_name: Infectious Ventriculitis


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C0700607

subject_name: digoxin antibodies Fab fragments

object_name: severe pre-eclampsia


subject: UMLS:C5418098

object_name: chronic myelomonocytic leukemia


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: pharyngitis


subject: CHEBI:51254

object_name: Pharyngitis, CTCAE


subject: CHEBI:51254

object_name: streptococcal infection


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:2676


subject: CHEBI:2676


subject: CHEBI:179553

subject_name: Hexyl 2-methylpropanoate


subject: CHEBI:179553


subject: CHEBI:179553


subject: CHEBI:51354

subject_name: Picibanil


subject: CHEBI:51354


subject: CHEBI:51354


subject: CHEBI:17334

subject_name: penicillin


subject: CHEBI:17334


subject: CHEBI:17334


subject: CHEBI:51344

subject_name: benzathine


subject: CHEBI:51344


subject: CHEBI:51344


subject: CHEBI:35218

subject_name: anthocyanin cation

object_name: type 2 diabetes mellitus


subject: CHEBI:35218

object_name: Insulin resistance


subject: CHEBI:35218

object_name: inherited lipid metabolism disorder


subject: CHEBI:35218

object_name: glucose metabolism disease


subject: CHEBI:36121

subject_name: flavylium


subject: CHEBI:36121


subject: CHEBI:36121


subject: CHEBI:36080

subject_name: protein

object_name: kidney disorder


subject: UMLS:C0033684

subject_name: Proteins


subject: PR:000000001


subject: CHEBI:75551

object_name: postmenopausal osteoporosis


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: Emergence Delirium


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor

object_name: Neoplasm Metastasis


subject: UMLS:C3146272

subject_name: MART-1 Antigen (vaccine component)

object_name: melanoma


subject: UMLS:C3146272


subject: UMLS:C1522481

subject_name: MART-1 Antigen


subject: UMLS:C1522481


subject: PR:000010436

subject_name: melanoma antigen recognized by T-cells 1


subject: PR:000010436


subject: MESH:C477385

subject_name: montanide ISA 51


subject: UMLS:C0281722

subject_name: gp100 Antigen


subject: CHEBI:74705

subject_name: Met-Leu

object_name: anemia


subject: CHEBI:74705

object_name: Anemia, CTCAE


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: UMLS:C2744441

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C2744441

object_name: Solid Neoplasm


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:63612

subject_name: Nelarabine

object_name: adult lymphoma


subject: CHEBI:63612

object_name: lymphoma


subject: CHEBI:63612

object_name: pediatric lymphoma


subject: CHEBI:138560

object_name: Hypoxemia


subject: CHEBI:138560

object_name: Hypoxia, CTCAE


subject: DRUGBANK:DB09337

subject_name: Medical air


subject: DRUGBANK:DB09337


subject: UNII:K21NZZ5Y0B

subject_name: AIR


subject: UNII:K21NZZ5Y0B


subject: PR:000022063

subject_name: aerotaxis receptor


subject: PR:000022063


subject: UMLS:C0001861

subject_name: Air (substance)


subject: UMLS:C0001861


subject: CHEBI:74947

subject_name: Thalidomide

object_name: oral cavity carcinoma


subject: CHEBI:74947

object_name: oral cavity cancer


subject: CHEBI:41423

subject_name: Celecoxib


subject: UNII:3A189DH42V

subject_name: Alemtuzumab


subject: PUBCHEM.COMPOUND:152031485

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PUBCHEM.COMPOUND:152031485

object_name: obesity


subject: PUBCHEM.COMPOUND:152031485

object_name: Obesity, CTCAE


subject: UNII:S7V5RX5WBZ


subject: UNII:S7V5RX5WBZ


subject: UNII:S7V5RX5WBZ


subject: PUBCHEM.COMPOUND:164938183

object_name: interstitial lung disease 2


subject: CHEMBL.COMPOUND:CHEMBL4298001

subject_name: CETRELIMAB

object_name: urinary bladder carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4298001

object_name: urinary bladder cancer


subject: CHEMBL.COMPOUND:CHEMBL4298001

object_name: childhood bladder carcinoma


subject: UMLS:C4329336


subject: UMLS:C4329336


subject: UMLS:C4329336


subject: UMLS:C4727717

subject_name: TAR 200


subject: UMLS:C4727717


subject: UMLS:C4727717


subject: UMLS:C5959686

subject_name: MIF Inhibitor IPG1094

object_name: Safety Issues


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone

object_name: Light for dates


subject: CHEBI:5862

subject_name: Idazoxan

object_name: Alzheimer disease type 1


subject: CHEBI:5862

object_name: Alzheimer disease


subject: CHEBI:93635

subject_name: Isocarboxazid


subject: CHEBI:93635


subject: CHEMBL.COMPOUND:CHEMBL4594592

object_name: Coronavinae infectious disease


subject: CHEMBL.COMPOUND:CHEMBL4594593


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: Drug-induced constipation


subject: CHEBI:46195

object_name: diverticulitis of colon


subject: CHEBI:46195

object_name: paralytic ileus


subject: CHEBI:46195

object_name: Colonic diverticula


subject: CHEBI:46195

object_name: rectal carcinoma


subject: CHEBI:46195

object_name: rectal cancer


subject: CHEBI:46195

object_name: colon carcinoma


subject: CHEBI:46195

object_name: colorectal cancer


subject: CHEBI:46195

object_name: colon cancer


subject: CHEBI:46195

object_name: Constipation


subject: CHEBI:46195

object_name: Constipation, CTCAE


subject: CHEBI:46195

object_name: Colon Neoplasm


subject: CHEBI:46195

object_name: Mechanical ileus


subject: CHEBI:46195

object_name: rectal neoplasm


subject: CHEBI:46195

object_name: ileus


subject: CHEBI:46195

object_name: Ileus, CTCAE


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: UMLS:C2917659


subject: CHEBI:5790

subject_name: Hydromorphone


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:5790


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:42797


subject: CHEBI:6121

subject_name: Ketamine


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:6121


subject: CHEBI:6129

subject_name: Ketorolac


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6129


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:60789

subject_name: bupivacaine hydrochloride hydrate


subject: CHEBI:60789


subject: CHEBI:60789


subject: CHEBI:60789


subject: CHEBI:60789


subject: CHEBI:60789


subject: CHEBI:60789


subject: CHEBI:60789


subject: CHEBI:60789


subject: CHEBI:60789


subject: CHEBI:60789


subject: CHEBI:60789


subject: CHEBI:60789


subject: CHEBI:60789


subject: CHEBI:60789


subject: CHEBI:60789


subject: CHEBI:3215

subject_name: Bupivacaine


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:3215


subject: CHEBI:167309

subject_name: Methadone


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:167309


subject: CHEBI:50731

subject_name: morphine sulfate pentahydrate


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:50731


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:17303


subject: CHEBI:7789

subject_name: Orphenadrine

object_name: Post-Operative Pain


subject: CHEBI:7789

object_name: Drug-induced constipation


subject: CHEBI:7789

object_name: diverticulitis of colon


subject: CHEBI:7789

object_name: paralytic ileus


subject: CHEBI:7789

object_name: Colonic diverticula


subject: CHEBI:7789

object_name: rectal carcinoma


subject: CHEBI:7789

object_name: rectal cancer


subject: CHEBI:7789

object_name: colon carcinoma


subject: CHEBI:7789

object_name: colorectal cancer


subject: CHEBI:7789

object_name: colon cancer


subject: CHEBI:7789

object_name: Constipation


subject: CHEBI:7789

object_name: Constipation, CTCAE


subject: CHEBI:7789

object_name: Colon Neoplasm


subject: CHEBI:7789

object_name: Mechanical ileus


subject: CHEBI:7789

object_name: rectal neoplasm


subject: CHEBI:7789

object_name: ileus


subject: CHEBI:7789

object_name: Ileus, CTCAE


subject: CHEBI:75722

subject_name: Tramadol


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:75722


subject: CHEBI:39112

subject_name: Bosutinib

object_name: leukemia


subject: CHEBI:39112

object_name: childhood leukemia


subject: UMLS:C1174836

object_name: Childhood Breast Carcinoma


subject: UMLS:C1174836

object_name: breast carcinoma


subject: UMLS:C1174836

object_name: breast cancer


subject: UMLS:C1174836


subject: UMLS:C1174836


subject: PUBCHEM.COMPOUND:13559282

subject_name: Ulipristal acetate

object_name: uterine fibroid


subject: CHEBI:71025

subject_name: ulipristal


subject: CHEBI:231178

object_name: cancer


subject: CHEBI:231178

object_name: neoplasm


subject: CHEBI:231178

object_name: Solid Neoplasm


subject: CHEBI:3215

object_name: epilepsy


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:6456


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:90001

subject_name: cystathionine ketimine

object_name: opiate dependence


subject: CHEBI:28082


subject: UMLS:C3813556

subject_name: Cancer/Testis Antigen


subject: PR:000050337

subject_name: mature calcitonin


subject: CHEBI:63610

subject_name: Misoprostol

object_name: placental retention


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: failure; transplant, kidney


subject: CHEBI:85078

object_name: Disorder of transplanted kidney


subject: CHEBI:85078

object_name: Renal Failure, CTCAE


subject: UMLS:C1577331

subject_name: Vitrase

object_name: Vitreous Hemorrhage, CTCAE 5.0


subject: UMLS:C1577331

object_name: Vitreous Hemorrhage, CTCAE 3.0


subject: UMLS:C1577331

object_name: Vitreous hemorrhage


subject: UMLS:C1577331

object_name: diabetic retinopathy


subject: CHEBI:231673

subject_name: Hyaluronidase

object_name: ocular hypotension


subject: PUBCHEM.COMPOUND:91820602


subject: CHEBI:80630

subject_name: Irinotecan

object_name: Malignant neoplasm of stomach stage III


subject: CHEBI:80630

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:80630

object_name: stage IV pancreatic cancer


subject: CHEBI:80630

object_name: Stage III Colorectal Cancer AJCC v6


subject: CHEBI:80630

object_name: Stage III Colorectal Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IV Colorectal Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IV Colorectal Cancer AJCC v6


subject: CHEBI:80630

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: CHEBI:80630

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: CHEBI:80630

object_name: Pancreatic carcinoma non-resectable


subject: CHEBI:80630

object_name: Unresectable Digestive System Adenocarcinoma


subject: CHEBI:80630

object_name: Cholangiocarcinoma non-resectable


subject: CHEBI:75179

subject_name: Trifluridine

object_name: Stage III Pancreatic Cancer AJCC v8


subject: CHEBI:75179

object_name: Pancreatic carcinoma stage III


subject: CHEBI:75179

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:75179


subject: CHEBI:75179

object_name: Pancreatic adenocarcinoma metastatic


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:75179

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:75179

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:75179


subject: CHEBI:75179

object_name: gastric adenocarcinoma


subject: CHEBI:75179

object_name: colorectal adenocarcinoma


subject: CHEBI:90879

subject_name: Tipiracil


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:90879

object_name: Malignant neoplasm of stomach stage III


subject: CHEBI:90879


subject: CHEBI:90879

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: CHEBI:90879

object_name: stage IV pancreatic cancer


subject: CHEBI:90879


subject: CHEBI:90879

object_name: Stage III Colorectal Cancer AJCC v6


subject: CHEBI:90879

object_name: Stage III Colorectal Cancer AJCC v7


subject: CHEBI:90879

object_name: Stage IV Colorectal Cancer AJCC v7


subject: CHEBI:90879

object_name: Stage IV Colorectal Cancer AJCC v6


subject: CHEBI:90879


subject: CHEBI:90879

object_name: Stage IVA Colorectal Cancer AJCC v7


subject: CHEBI:90879

object_name: Stage IVB Colorectal Cancer AJCC v7


subject: CHEBI:90879

object_name: Pancreatic carcinoma non-resectable


subject: CHEBI:90879

object_name: Unresectable Digestive System Adenocarcinoma


subject: CHEBI:90879

object_name: Cholangiocarcinoma non-resectable


subject: CHEBI:90879


subject: CHEBI:90879


subject: CHEBI:3286

subject_name: Cabergoline

object_name: ovarian hyperstimulation syndrome


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: acromegaly


subject: UNII:NQX9KB6PCL

object_name: Acral overgrowth


subject: UNII:NQX9KB6PCL

object_name: pituitary gland disorder


subject: UMLS:C0384570

subject_name: Recombinant Human Growth Hormone


subject: UMLS:C0384570


subject: UMLS:C0384570


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: UMLS:C2825029

subject_name: Recombinant Human Growth Hormone [EPC]


subject: UMLS:C2825029


subject: UMLS:C2825029


subject: CHEBI:2668

subject_name: Amlodipine

object_name: Angina pectoris


subject: CHEBI:2668

object_name: Variant Angina


subject: CHEBI:74224

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:74224

object_name: Embolism, Tumor


subject: CHEBI:74224

object_name: Neoplasm Metastasis


subject: CHEBI:74224

object_name: renal carcinoma


subject: CHEBI:74224

object_name: kidney neoplasm


subject: CHEBI:74224

object_name: kidney cancer


subject: CHEBI:74224

object_name: lung cancer


subject: CHEBI:74224

object_name: lung neoplasm


subject: CHEBI:74224

object_name: lung carcinoma


subject: CHEBI:74224

object_name: melanoma


subject: CHEBI:27514

subject_name: genistin


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:27514


subject: CHEBI:28088

subject_name: Genistein


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:28088


subject: CHEBI:28088


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Previously Treated Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:1805

object_name: De Novo Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:1805

object_name: refractory anemia with excess blasts in transformation


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:91397

subject_name: Ibrutinib


subject: CHEBI:91397


subject: CHEBI:91397

object_name: Secondary Myelodysplastic Syndrome


subject: CHEBI:91397


subject: CHEBI:91397

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:91397

object_name: chronic myelomonocytic leukemia


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Advanced Malignant Solid Neoplasm


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:17549

subject_name: Aminolevulinic acid

object_name: nevoid basal cell carcinoma syndrome


subject: CHEBI:66903

subject_name: Vismodegib


subject: UNII:7CND0TX59N

subject_name: Potassium octanoate

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UNII:7CND0TX59N

object_name: stage IV pancreatic cancer


subject: UNII:7CND0TX59N

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: UNII:7CND0TX59N

object_name: Pancreatic carcinoma recurrent


subject: UNII:7CND0TX59N

object_name: Stage III Pancreatic Cancer AJCC v8


subject: UNII:7CND0TX59N

object_name: Pancreatic carcinoma stage III


subject: UNII:7CND0TX59N

object_name: Stage III Pancreatic Cancer AJCC v6 and v7


subject: UNII:7CND0TX59N

object_name: pancreatic ductal adenocarcinoma


subject: UNII:7CND0TX59N

object_name: pancreatic acinar cell carcinoma


subject: CHEBI:25646

subject_name: octanoate


subject: CHEBI:25646


subject: CHEBI:25646


subject: CHEBI:25646


subject: CHEBI:25646


subject: CHEBI:25646


subject: CHEBI:25646


subject: CHEBI:25646


subject: CHEBI:25646


subject: CHEBI:28837

subject_name: Caprylic acid


subject: CHEBI:28837


subject: CHEBI:28837


subject: CHEBI:28837


subject: CHEBI:28837


subject: CHEBI:28837


subject: CHEBI:28837


subject: CHEBI:28837


subject: CHEBI:28837


subject: CHEBI:474053

subject_name: Cefazolin

object_name: Inguinal hernia


subject: PUBCHEM.COMPOUND:3467

subject_name: gentamicin


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: nasopharyngeal carcinoma


subject: CHEBI:39548

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEBI:39548

object_name: Disorder due to radiotherapy


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Staphylococcus aureus septicaemia


subject: CHEBI:37941

object_name: Staphylococcus aureus endocarditis


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)

object_name: Kallmann syndrome


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: PUBCHEM.COMPOUND:21888462

subject_name: Menotrophin

object_name: hypogonadotropic hypogonadism


subject: PUBCHEM.COMPOUND:21888462

object_name: Klinefelter syndrome


subject: PUBCHEM.COMPOUND:21888462


subject: UMLS:C0025326

subject_name: Menotropins


subject: UMLS:C0025326


subject: UMLS:C0025326


subject: CHEBI:231614

subject_name: Nivolumab

object_name: mucosal melanoma


subject: CHEBI:231614

object_name: Unresectable Cutaneous Melanoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEMBL.COMPOUND:CHEMBL5314348

subject_name: BIVALIRUDIN

object_name: heparin-induced thrombocytopenia


subject: UMLS:C1314413

subject_name: INJECTION, BIVALIRUDIN, 1 MG ADMINISTERED


subject: CHEBI:59173

subject_name: Bivalirudin


subject: UMLS:C0003015

object_name: chronic kidney disease


subject: UMLS:C0003015

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C0521942

subject_name: Angiotensin II receptor antagonist


subject: UMLS:C0521942


subject: UMLS:C1827106

subject_name: Dipeptidyl-Peptidase IV Inhibitors


subject: UMLS:C1827106


subject: CHEBI:71196

subject_name: glucagon-like peptide-1 receptor agonist


subject: CHEBI:71196


subject: CHEBI:38215

subject_name: calcium channel blocker


subject: CHEBI:38215


subject: UMLS:C0006684

subject_name: Calcium Channel Blockers


subject: UMLS:C0006684


subject: UMLS:C5666925

subject_name: Anti-claudin 18.2 Antibody-drug Conjugate CPO102

object_name: Stomach cancer


subject: UMLS:C5666925

object_name: gastric cancer


subject: UMLS:C5666925

object_name: pancreatic neoplasm


subject: UMLS:C5666925

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5666925

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside

object_name: Stage II Renal Cell Cancer AJCC v7


subject: PUBCHEM.COMPOUND:131769963

object_name: Stage I Renal Cell Carcinoma


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:38940


subject: CHEBI:5494

subject_name: ritropirronium bromide

object_name: Critical Illness


subject: CHEBI:94449

subject_name: Glycopyrronium


subject: CHEBI:7514

subject_name: Neostigmine


subject: CHEBI:8884

subject_name: Rocuronium


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex


subject: CHEBI:90836

subject_name: cangrelor tetrasodium

object_name: myocardial infarction


subject: CHEBI:90836

object_name: Myocardial Infarction, CTCAE


subject: CHEBI:90836

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:90836

object_name: ST-elevation myocardial infarction


subject: CHEBI:90836

object_name: acute coronary syndrome


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: thyrotoxicosis


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: HMDB:HMDB0001349

subject_name: Selenium


subject: UMLS:C0521939

subject_name: Selenium supplement


subject: CHEBI:10056

subject_name: Xanomeline

object_name: Cognitive impairment


subject: CHEBI:10056

object_name: Schizophrenic psychoses


subject: PUBCHEM.COMPOUND:5284632

subject_name: Trospium


subject: PUBCHEM.COMPOUND:5284632


subject: UNII:H4X2M2NN5N

subject_name: TAFETINIB

object_name: neoplasm


subject: UMLS:C3713828

subject_name: tafetinib


subject: CHEBI:91400

subject_name: Afatinib

object_name: small cell lung carcinoma


subject: CHEBI:233453

object_name: herpes zoster


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Ischemic stroke


subject: CHEBI:8378

subject_name: Prednisolone


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Peutz-Jeghers syndrome


subject: PUBCHEM.COMPOUND:70789204

object_name: Neoplastic Processes


subject: PUBCHEM.COMPOUND:86217377

subject_name: Oxybutynin AL

object_name: urgency urinary incontinence


subject: CHEBI:144551

subject_name: Oxybutynin


subject: CHEBI:94789

subject_name: Trimetazidine

object_name: Acute-On-Chronic Liver Failure


subject: CHEBI:94789

object_name: acute-on-chronic liver failure


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: mycosis fungoides


subject: CHEBI:175901

object_name: Sezary syndrome


subject: CHEBI:175901

object_name: Mycosis fungoides/Sezary syndrome


subject: CHEBI:135736

subject_name: Sitaxentan

object_name: chronic kidney disease


subject: CHEBI:135736

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:135736

object_name: Blood Pressure Finding


subject: CHEBI:135736

object_name: Systemic arterial pressure


subject: CHEBI:135736

object_name: proteinuria


subject: CHEBI:135736

object_name: Proteinuria of undiagnosed cause


subject: CHEBI:135736

object_name: Proteinuria, CTCAE 3.0


subject: CHEBI:135736

object_name: Proteinuria, CTCAE 5.0


subject: UMLS:C0795657

subject_name: Aralast

object_name: neuromyelitis optica


subject: PR:000014678


subject: UMLS:C0002191

subject_name: alpha 1-antitrypsin


subject: UMLS:C5206855

subject_name: Lignin-derived Polyphenolic Composition with Ammonium Molybdate BP-C2

object_name: prostate carcinoma


subject: UMLS:C5206855

object_name: prostate cancer


subject: CHEBI:39112

subject_name: Bosutinib

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:39112

object_name: amyotrophic lateral sclerosis


subject: UNII:QMS40680K6

subject_name: Palifermin

object_name: HIV infection


subject: UNII:2R27AB6766

subject_name: Caplacizumab


subject: UMLS:C4733446

object_name: small cell lung carcinoma


subject: CHEBI:27732

subject_name: Caffeine

object_name: schizophrenia


subject: CHEBI:233364

subject_name: Bryostatin

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:233364

object_name: Malignant neoplasm of stomach stage III


subject: CHEBI:88353

subject_name: Bryostatin 1


subject: CHEBI:88353


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:15727

subject_name: Carnosine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:15727

object_name: obesity


subject: CHEBI:15727

object_name: Obesity, CTCAE


subject: UMLS:C0007267

subject_name: carnosine


subject: UMLS:C0007267


subject: UMLS:C0007267


subject: CHEBI:6887

subject_name: Methylphenidate

object_name: Childhood Brain Neoplasm


subject: PUBCHEM.COMPOUND:188025

object_name: Cancer Fatigue


subject: PUBCHEM.COMPOUND:188025

object_name: Poisoning by, adverse effect of and underdosing of methylphenidate


subject: PUBCHEM.COMPOUND:188025


subject: CHEBI:228596

subject_name: MPH


subject: CHEBI:228596


subject: CHEBI:228596


subject: PR:000002069


subject: PR:000002069


subject: PR:000002069


subject: CHEBI:10033

subject_name: Warfarin

object_name: ANTICOAGULATION (finding)


subject: DRUGBANK:DB16492

object_name: ulcerative colitis


subject: CHEBI:188074

object_name: Depressed mood


subject: CHEBI:188074

object_name: Cancer patients and suicide and depression


subject: CHEBI:188074

object_name: Depressed - symptom


subject: CHEBI:188074

object_name: Depression, CTCAE


subject: CHEBI:188074

object_name: bipolar disorder


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:50122


subject: CHEBI:46345

subject_name: Fluorouracil

object_name: Bowen's Disease


subject: CHEBI:724125

subject_name: Methyl aminolevulinate


subject: UNII:CVN0S9V910

subject_name: MAL


subject: CHEBI:15595


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: benign neoplasm


subject: PUBCHEM.COMPOUND:6096882

object_name: Benign obstetric neoplasm


subject: PUBCHEM.COMPOUND:6096882

object_name: respiratory system benign neoplasm


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UNII:C4V974V932


subject: UNII:6Z4B5PJ4OP

subject_name: AMG 330

object_name: Myelodysplasia


subject: UNII:6Z4B5PJ4OP

object_name: Adult Myelodysplastic Syndrome


subject: UNII:6Z4B5PJ4OP

object_name: childhood myelodysplastic syndrome


subject: UNII:6Z4B5PJ4OP

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C3851031


subject: UMLS:C3851031


subject: UMLS:C3851031


subject: UMLS:C3851031


subject: UMLS:C0813973

subject_name: Medical Marijuana

object_name: Tourette syndrome in adolescence


subject: CHEBI:194535

subject_name: moscovium atom


subject: CHEBI:34342


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: CHEBI:177517

subject_name: Bifeprunox

object_name: bipolar depression


subject: CHEBI:34967

subject_name: Rimonabant

object_name: maturity-onset diabetes of the young type 1


subject: CHEBI:34967

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:34967

object_name: obesity


subject: CHEBI:34967

object_name: Obesity, CTCAE


subject: CHEBI:8774

subject_name: Ramipril

object_name: LEFT VENTRICULAR FUNCTION SYSTOLIC DYSFUNCTION


subject: CHEBI:8774

object_name: LEFT VENTRICULAR FUNCTION DIASTOLIC DYSFUNCTION


subject: PUBCHEM.COMPOUND:135565609

subject_name: Hetrombopag olamine

object_name: thrombocytopenia due to immune destruction


subject: PUBCHEM.COMPOUND:135565609

object_name: autoimmune thrombocytopenic purpura


subject: UMLS:C5418132

subject_name: Hetrombopag Olamine


subject: UMLS:C5418132


subject: UMLS:C0720141

subject_name: Econopred Plus

object_name: cataract


subject: UMLS:C0720141

object_name: Cataract, CTCAE 3.0


subject: UMLS:C0720141

object_name: Cataract, CTCAE 5.0


subject: UMLS:C0720141

object_name: cataract on exam (physical finding)


subject: UMLS:C0720141

object_name: glaucoma


subject: UMLS:C0720141

object_name: Glaucoma, CTCAE


subject: PUBCHEM.COMPOUND:4895

subject_name: Pred Forte


subject: PUBCHEM.COMPOUND:4895


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: PUBCHEM.COMPOUND:164888937

subject_name: Gallium Ga 68 FAPI-46

object_name: Localized Pancreatic Adenocarcinoma


subject: PUBCHEM.COMPOUND:164888937

object_name: Resectable Pancreatic Ductal Adenocarcinoma


subject: PUBCHEM.COMPOUND:164888937

object_name: Stage 0 Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:164888937

object_name: Stage I Pancreatic Cancer AJCC v8


subject: PUBCHEM.COMPOUND:164888937

object_name: Stage IIA Pancreatic Cancer AJCC v8


subject: UMLS:C5237268

subject_name: Gallium Ga 68 FAPi-46


subject: UMLS:C5237268


subject: UMLS:C5237268


subject: UMLS:C5237268


subject: UMLS:C5237268


subject: UMLS:C5926468

subject_name: FAPi-46 GA-68


subject: UMLS:C5926468


subject: UMLS:C5926468


subject: UMLS:C5926468


subject: UMLS:C5926468


subject: GTOPDB:7984

subject_name: edrecolomab

object_name: colon mucinous adenocarcinoma


subject: GTOPDB:7984

object_name: colon signet ring cell adenocarcinoma


subject: GTOPDB:7984

object_name: stage IIC colon cancer


subject: GTOPDB:7984

object_name: Stage IIC Colon Cancer AJCC v8


subject: GTOPDB:7984

object_name: Stage IIC Colon Cancer AJCC v7


subject: GTOPDB:7984

object_name: Stage IIB Colon Cancer AJCC v7


subject: GTOPDB:7984

object_name: Stage IIB Colon Cancer AJCC v8


subject: GTOPDB:7984

object_name: malignant large intestine neoplasm stage IIb


subject: GTOPDB:7984

object_name: Stage IIA Colon Cancer AJCC v8


subject: GTOPDB:7984

object_name: malignant large intestine neoplasm stage IIa


subject: GTOPDB:7984

object_name: Stage IIA Colon Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL2108955

subject_name: EDRECOLOMAB


subject: CHEMBL.COMPOUND:CHEMBL2108955


subject: CHEMBL.COMPOUND:CHEMBL2108955


subject: CHEMBL.COMPOUND:CHEMBL2108955


subject: CHEMBL.COMPOUND:CHEMBL2108955


subject: CHEMBL.COMPOUND:CHEMBL2108955


subject: CHEMBL.COMPOUND:CHEMBL2108955


subject: CHEMBL.COMPOUND:CHEMBL2108955


subject: CHEMBL.COMPOUND:CHEMBL2108955


subject: CHEMBL.COMPOUND:CHEMBL2108955


subject: CHEMBL.COMPOUND:CHEMBL2108955


subject: UMLS:C0279218


subject: UMLS:C0279218


subject: UMLS:C0279218


subject: UMLS:C0279218


subject: UMLS:C0279218


subject: UMLS:C0279218


subject: UMLS:C0279218


subject: UMLS:C0279218


subject: UMLS:C0279218


subject: UMLS:C0279218


subject: UMLS:C0279218


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Chronic lymphocytic leukaemia refractory


subject: UNII:4Z63YK6E0E

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UNII:4Z63YK6E0E

object_name: Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma


subject: UNII:4Z63YK6E0E

object_name: B-cell small lymphocytic lymphoma refractory


subject: UNII:4Z63YK6E0E

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:91397

subject_name: Ibrutinib


subject: CHEBI:144903

subject_name: Pro-Arg-Pro

object_name: muscle injury


subject: CHEBI:61848


subject: PR:000013192


subject: UniProtKB:P05142

subject_name: PRH1_MOUSE Proline-rich protein HaeIII subfamily 1 (sprot)


subject: PR:000013551


subject: PR:000003551

subject_name: ATP-binding cassette sub-family B member 6


subject: UniProtKB:P67986

subject_name: PRIO_CEREN Major prion protein (sprot)


subject: PR:000001886

subject_name: major prion protein


subject: PR:000030465

subject_name: C4b-binding protein alpha chain


subject: PR:000013555

subject_name: proline-rich protein 2


subject: UniProtKB:P05143

subject_name: PRP2_MOUSE Proline-rich protein 2 (sprot)


subject: PR:000032963

subject_name: proline-rich protein HaeIII subfamily 1


subject: CHEBI:60791

subject_name: Xylocard

object_name: pancreatic neoplasm


subject: CHEBI:60791

object_name: exocrine pancreatic carcinoma


subject: CHEBI:60791

object_name: malignant pancreatic neoplasm


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:6456


subject: CHEBI:33838

subject_name: nucleoside

object_name: hepatitis B


subject: CHEBI:33838

object_name: chronic hepatitis B virus infection


subject: CHEBI:36976

subject_name: nucleotide


subject: CHEBI:36976


subject: CHEBI:33792

subject_name: canonical ribonucleoside residue


subject: CHEBI:33792


subject: UniProtKB:P13383

subject_name: nucleolin (rat)


subject: UniProtKB:P13383


subject: PR:000005195

subject_name: cell division cycle protein 27


subject: PR:000005195


subject: PR:000011479


subject: PR:000011479


subject: PR:000011038

subject_name: nucleolin


subject: PR:000011038


subject: CHEBI:91849

subject_name: Ergobasin

object_name: postpartum hemorrhage


subject: CHEBI:91849

object_name: Post-partum hemorrhage


subject: CHEBI:4822

subject_name: Ergometrine


subject: CHEBI:4822


subject: CHEBI:187232


subject: CHEBI:187232


subject: CHEBI:27595


subject: CHEBI:27595


subject: CHEBI:57404

subject_name: Enzaprost F


subject: CHEBI:57404


subject: CHEBI:15553

subject_name: Dinoprost


subject: CHEBI:15553


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IV Esophageal Cancer AJCC v6


subject: PUBCHEM.COMPOUND:70789204

object_name: Stage IV Esophageal Cancer AJCC v7


subject: PUBCHEM.COMPOUND:70789204

object_name: stage IV esophageal cancer


subject: PUBCHEM.COMPOUND:70789204

object_name: Oesophageal carcinoma recurrent


subject: PUBCHEM.COMPOUND:70789204

object_name: Gastric Mixed Adenocarcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: gastric intestinal type adenocarcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: diffuse gastric adenocarcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: recurrent gastric cancer


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:15640


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: PUBCHEM.COMPOUND:91973920

subject_name: Grape Seed P.E.

object_name: hyperlipidemia


subject: PUBCHEM.COMPOUND:91973920

object_name: hyperlipoproteinemia


subject: PUBCHEM.COMPOUND:91973920

object_name: Hyperlipidemia, CTCAE


subject: PUBCHEM.COMPOUND:91973920

object_name: Serum lipids high (finding)


subject: MESH:D056604

subject_name: Grape Seed Extract


subject: MESH:D056604


subject: MESH:D056604


subject: MESH:D056604


subject: DRUGBANK:DB16606

subject_name: Vitis vinifera seed


subject: DRUGBANK:DB16606


subject: DRUGBANK:DB16606


subject: DRUGBANK:DB16606


subject: CHEBI:36796

subject_name: duloxetine

object_name: attention deficit hyperactivity disorder, inattentive type


subject: PUBCHEM.COMPOUND:11525088

subject_name: Elesclomol sodium

object_name: Recurrent Primary Peritoneal Carcinoma


subject: PUBCHEM.COMPOUND:11525088

object_name: Recurrent Fallopian Tube Carcinoma


subject: PUBCHEM.COMPOUND:11525088

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:11525088

object_name: primary peritoneal serous adenocarcinoma


subject: PUBCHEM.COMPOUND:11525088

object_name: peritoneal serous adenocarcinoma


subject: PUBCHEM.COMPOUND:11525088

object_name: fallopian tube transitional cell carcinoma


subject: PUBCHEM.COMPOUND:11525088

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: PUBCHEM.COMPOUND:11525088

object_name: fallopian tube clear cell adenocarcinoma


subject: PUBCHEM.COMPOUND:11525088

object_name: ovarian Brenner tumor


subject: PUBCHEM.COMPOUND:11525088

object_name: fallopian tube serous adenocarcinoma


subject: PUBCHEM.COMPOUND:11525088

object_name: fallopian tube mucinous adenocarcinoma


subject: PUBCHEM.COMPOUND:11525088

object_name: fallopian tube endometrioid adenocarcinoma


subject: PUBCHEM.COMPOUND:11525088

object_name: undifferentiated ovarian carcinoma


subject: PUBCHEM.COMPOUND:11525088

object_name: ovarian clear cell adenocarcinoma


subject: PUBCHEM.COMPOUND:11525088

object_name: ovarian endometrioid adenocarcinoma


subject: PUBCHEM.COMPOUND:11525088

object_name: ovarian serous adenocarcinoma


subject: PUBCHEM.COMPOUND:11525088

object_name: ovarian seromucinous carcinoma


subject: PUBCHEM.COMPOUND:11525088

object_name: Primary mucinous adenocarcinoma of ovary


subject: PUBCHEM.COMPOUND:11525088

object_name: ovarian mucinous adenocarcinoma


subject: UNII:L219C7807V

subject_name: ELESCLOMOL SODIUM

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UNII:L219C7807V

object_name: Recurrent Fallopian Tube Carcinoma


subject: UNII:L219C7807V

object_name: Recurrent ovarian cancer


subject: UNII:L219C7807V

object_name: primary peritoneal serous adenocarcinoma


subject: UNII:L219C7807V

object_name: peritoneal serous adenocarcinoma


subject: UNII:L219C7807V

object_name: fallopian tube transitional cell carcinoma


subject: UNII:L219C7807V

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: UNII:L219C7807V

object_name: fallopian tube clear cell adenocarcinoma


subject: UNII:L219C7807V

object_name: ovarian Brenner tumor


subject: UNII:L219C7807V

object_name: fallopian tube serous adenocarcinoma


subject: UNII:L219C7807V

object_name: fallopian tube mucinous adenocarcinoma


subject: UNII:L219C7807V

object_name: fallopian tube endometrioid adenocarcinoma


subject: UNII:L219C7807V

object_name: undifferentiated ovarian carcinoma


subject: UNII:L219C7807V

object_name: ovarian clear cell adenocarcinoma


subject: UNII:L219C7807V

object_name: ovarian endometrioid adenocarcinoma


subject: UNII:L219C7807V

object_name: ovarian serous adenocarcinoma


subject: UNII:L219C7807V

object_name: ovarian seromucinous carcinoma


subject: UNII:L219C7807V

object_name: Primary mucinous adenocarcinoma of ovary


subject: UNII:L219C7807V

object_name: ovarian mucinous adenocarcinoma


subject: UMLS:C2699865

subject_name: Elesclomol Sodium

object_name: Recurrent Primary Peritoneal Carcinoma


subject: UMLS:C2699865

object_name: Recurrent Fallopian Tube Carcinoma


subject: UMLS:C2699865

object_name: Recurrent ovarian cancer


subject: UMLS:C2699865

object_name: primary peritoneal serous adenocarcinoma


subject: UMLS:C2699865

object_name: peritoneal serous adenocarcinoma


subject: UMLS:C2699865

object_name: fallopian tube transitional cell carcinoma


subject: UMLS:C2699865

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: UMLS:C2699865

object_name: fallopian tube clear cell adenocarcinoma


subject: UMLS:C2699865

object_name: ovarian Brenner tumor


subject: UMLS:C2699865

object_name: fallopian tube serous adenocarcinoma


subject: UMLS:C2699865

object_name: fallopian tube mucinous adenocarcinoma


subject: UMLS:C2699865

object_name: fallopian tube endometrioid adenocarcinoma


subject: UMLS:C2699865

object_name: undifferentiated ovarian carcinoma


subject: UMLS:C2699865

object_name: ovarian clear cell adenocarcinoma


subject: UMLS:C2699865

object_name: ovarian endometrioid adenocarcinoma


subject: UMLS:C2699865

object_name: ovarian serous adenocarcinoma


subject: UMLS:C2699865

object_name: ovarian seromucinous carcinoma


subject: UMLS:C2699865

object_name: Primary mucinous adenocarcinoma of ovary


subject: UMLS:C2699865

object_name: ovarian mucinous adenocarcinoma


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib

object_name: Recurrent Endometrial Cancer


subject: PUBCHEM.COMPOUND:51038893

object_name: Advanced Endometrial Carcinoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Metastatic Endometrial Carcinoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Recurrent Platinum-Resistant Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Recurrent Primary Peritoneal Carcinoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Recurrent Fallopian Tube Carcinoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Metastatic Platinum-Resistant Ovarian Carcinoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Stage III Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:51038893

object_name: Stage IV Uterine Corpus Cancer AJCC v8


subject: PUBCHEM.COMPOUND:51038893

object_name: Metastatic Primary Peritoneal Carcinoma


subject: PUBCHEM.COMPOUND:51038893

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:51038893

object_name: Metastatic Fallopian Tube Carcinoma


subject: UNII:317UBD60ML

subject_name: Pelcitoclax


subject: UNII:317UBD60ML


subject: UNII:317UBD60ML


subject: UNII:317UBD60ML


subject: UNII:317UBD60ML


subject: UNII:317UBD60ML


subject: UNII:317UBD60ML


subject: UNII:317UBD60ML


subject: UNII:317UBD60ML


subject: UNII:317UBD60ML


subject: UNII:317UBD60ML


subject: UNII:317UBD60ML


subject: GTOPDB:13796

subject_name: serplulimab

object_name: cervical cancer


subject: GTOPDB:13796

object_name: cervical carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4594550


subject: GTOPDB:13334

subject_name: bezlotoxumab

object_name: inflammatory bowel disease


subject: GTOPDB:13334

object_name: clostridium difficile infection


subject: GTOPDB:13334

object_name: inflammatory bowel disease 1


subject: GTOPDB:13334

object_name: Crohn disease


subject: GTOPDB:13334

object_name: ulcerative colitis


subject: UNII:4H5YMK1H2E

subject_name: Bezlotoxumab


subject: UNII:4H5YMK1H2E


subject: UNII:4H5YMK1H2E


subject: UNII:4H5YMK1H2E


subject: CHEBI:8378

subject_name: Prednisolone

object_name: prostate neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UNII:48IJA0E92C

subject_name: IFETROBAN SODIUM

object_name: cardiovascular disorder


subject: UNII:48IJA0E92C

object_name: Vasodilation disorder


subject: UMLS:C2825686

subject_name: Ifetroban Sodium


subject: UMLS:C2825686


subject: CHEBI:84500

subject_name: varenicline

object_name: Friedreich ataxia


subject: CHEBI:91368

subject_name: Enzastaurin

object_name: adult lymphoma


subject: CHEBI:91368

object_name: lymphoma


subject: CHEBI:91368

object_name: pediatric lymphoma


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine

object_name: carcinoma of esophagus


subject: PUBCHEM.COMPOUND:44424639

object_name: esophageal cancer


subject: PUBCHEM.COMPOUND:44424639

object_name: Childhood Esophageal Carcinoma


subject: PUBCHEM.COMPOUND:44424639

object_name: neoplasm of esophagus


subject: PUBCHEM.COMPOUND:44424639

object_name: Stomach cancer


subject: PUBCHEM.COMPOUND:44424639

object_name: gastric cancer


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:8746

subject_name: Levosalbutamol

object_name: Hyperkalemia, CTCAE


subject: CHEBI:8746

object_name: Hyperkalemia


subject: CHEBI:49668

subject_name: Gefitinib

object_name: lung large cell carcinoma


subject: CHEBI:49668

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:49668

object_name: Non-small cell lung cancer stage IIIA


subject: CHEBI:49668

object_name: squamous cell lung carcinoma


subject: CHEBI:49668

object_name: minimally invasive lung adenocarcinoma


subject: CHEBI:49668

object_name: adenosquamous lung carcinoma


subject: CHEBI:49668

object_name: lung adenocarcinoma


subject: UMLS:C1955477

subject_name: Glucose (oral)

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C1955477

object_name: obesity


subject: UMLS:C1955477

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:74434636

subject_name: Dotanoc

object_name: pulmonary sarcoidosis


subject: CHEBI:16811

subject_name: Racemethionine


subject: UMLS:C0034504

subject_name: racemethionine


subject: UMLS:C0873173

subject_name: red yeast rice extract

object_name: Hypercholesterolemia


subject: MESH:C117343

subject_name: red yeast rice


subject: UMLS:C0813973

subject_name: Medical Marijuana

object_name: cannabis abuse


subject: UMLS:C0813973

object_name: liver carcinoma


subject: CHEBI:50838

subject_name: Drospirenone

object_name: endometrial polyp


subject: CHEBI:50838

object_name: Endometrial Diseases


subject: PUBCHEM.COMPOUND:9995208

subject_name: Estetrol


subject: PUBCHEM.COMPOUND:9995208


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:4903


subject: PUBCHEM.COMPOUND:13175121

subject_name: Dienogest


subject: PUBCHEM.COMPOUND:13175121


subject: PUBCHEM.COMPOUND:13505135

subject_name: Nomegestrol acetate


subject: PUBCHEM.COMPOUND:13505135


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: UMLS:C4722527

subject_name: E7389 Liposomal Formulation

object_name: Childhood Solid Neoplasm


subject: UMLS:C4722527

object_name: Adult Solid Neoplasm


subject: UMLS:C4722527

object_name: Solid Neoplasm


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: skin disorder


subject: CHEBI:94518

object_name: Inflammation


subject: CHEBI:94518

object_name: Edema of the upper limbs


subject: CHEBI:94518

object_name: Skin Bruise


subject: CHEBI:94518

object_name: Easy Bruising


subject: CHEBI:94518

object_name: Ecchymosis


subject: CHEBI:94518

object_name: Contusions


subject: CHEBI:94518

object_name: reported bruising (history)


subject: CHEBI:94518

object_name: Bruising, CTCAE


subject: CHEBI:94518

object_name: hematoma


subject: CHEBI:94518

object_name: Hematoma, CTCAE


subject: PUBCHEM.COMPOUND:147912

subject_name: Posaconazole

object_name: inflammatory bowel disease 1


subject: PUBCHEM.COMPOUND:147912

object_name: Crohn disease


subject: CHEBI:35341

subject_name: steroid

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:35341

object_name: thyroid disease


subject: UMLS:C5782153

subject_name: Steroid [EPC]


subject: UMLS:C5782153


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: Hepatic impairment


subject: UMLS:C1328139

object_name: diffuse large B-cell lymphoma


subject: UMLS:C1328139

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: UMLS:C1328139

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: osteoarthritis


subject: PUBCHEM.COMPOUND:6335487

object_name: Hemodynamic instability


subject: MESH:D000077325

subject_name: Ringer's Lactate


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: neoplasm


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Post-Operative Pain


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: MESH:C456740

object_name: diabetic neuropathy


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: essential thrombocythemia


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:231347

subject_name: Triapine

object_name: Blast Phase


subject: CHEBI:231347

object_name: leukemia, myeloid, accelerated-phase


subject: CHEBI:231347

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:231347

object_name: chronic myelomonocytic leukemia


subject: CHEBI:231347

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: CHEBI:231347

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:231347

object_name: chronic eosinophilic leukemia


subject: CHEBI:231347


subject: CHEBI:231347

object_name: acquired polycythemia vera


subject: CHEBI:231347

object_name: myelofibrosis


subject: UMLS:C4687432

subject_name: Allogeneic GM-CSF-secreting Breast Cancer Vaccine SV-BR-1-GM

object_name: Metastatic Breast Carcinoma


subject: UMLS:C4687432

object_name: Breast cancer recurrent


subject: UMLS:C4687432

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C4687432

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C4687432

object_name: Refractory Breast Carcinoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:H9CK7SS0T6

subject_name: recombinant interferon alpha 2b-like protein


subject: UNII:H9CK7SS0T6


subject: UNII:H9CK7SS0T6


subject: UNII:H9CK7SS0T6


subject: UNII:H9CK7SS0T6


subject: UMLS:C3273450

subject_name: Novaferon


subject: UMLS:C3273450


subject: UMLS:C3273450


subject: UMLS:C3273450


subject: UMLS:C3273450


subject: CHEBI:10429

subject_name: Lapachone

object_name: cancer


subject: CHEBI:10429

object_name: neoplasm


subject: UMLS:C1328233

subject_name: ARQ 501


subject: UMLS:C1328233


subject: UMLS:C5206656

subject_name: FLT3/BTK Inhibitor CG 806

object_name: non-Hodgkin lymphoma


subject: UMLS:C5206656

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:63629

subject_name: Tizanidine

object_name: Cognitive impairment


subject: CHEBI:3654

subject_name: Chlorthalidone

object_name: Prehypertension


subject: CHEBI:3654

object_name: cardiovascular disorder


subject: CHEBI:2639

subject_name: Amiloride


subject: UNII:QC4F7FKK7I

subject_name: Faricimab

object_name: background diabetic retinopathy


subject: CHEBI:64212

subject_name: Exisulind

object_name: breast neoplasm


subject: CHEBI:64212

object_name: Neoplasm Metastasis


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Abnormal renal physiology


subject: CHEBI:68558

subject_name: Ticagrelor

object_name: Platelet aggregation test result


subject: CHEBI:68558


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: irritable bowel syndrome


subject: PUBCHEM.COMPOUND:16760629

subject_name: Cethrin

object_name: spinal cord injury


subject: UMLS:C3253820

subject_name: cethrin


subject: UMLS:C3253819


subject: UNII:PA05MFH3I7

object_name: leukemia


subject: UNII:PA05MFH3I7

object_name: childhood leukemia


subject: UNII:PA05MFH3I7


subject: CHEBI:95165

object_name: Primary malignant neoplasm of ovary


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:31355

subject_name: Carboplatin


subject: UMLS:C2830069

subject_name: Smoothened Antagonist LDE225

object_name: prostate carcinoma


subject: UMLS:C2830069

object_name: prostate cancer


subject: CHEBI:90863

subject_name: Sonidegib


subject: CHEBI:90863


subject: UMLS:C0935868

subject_name: paclitaxel liposome

object_name: cancer


subject: UMLS:C0935868

object_name: neoplasm


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: chronic obstructive pulmonary disease


subject: UNII:78FE5XHE27

object_name: Diabetic peripheral neuropathic pain


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol

object_name: Low back pain


subject: PUBCHEM.COMPOUND:1972

subject_name: Fungizone

object_name: disseminated candidiasis


subject: PUBCHEM.COMPOUND:1972

object_name: candidiasis, invasive


subject: PUBCHEM.COMPOUND:1972

object_name: candidemia


subject: CHEBI:2682

subject_name: Amphotericin B


subject: CHEBI:2682


subject: CHEBI:2682


subject: UNII:C137DTR5RG

subject_name: THEOPHYLLINE

object_name: Syncope Related to COVID-19


subject: UNII:C137DTR5RG

object_name: Syncope, CTCAE 5.0


subject: UNII:C137DTR5RG

object_name: Syncope


subject: CHEBI:28177

subject_name: Theophylline


subject: CHEBI:28177


subject: CHEBI:28177


subject: UMLS:C5785351

subject_name: Anti-CD32B Monoclonal Antibody BI-1607

object_name: HER2-positive gastric cancer


subject: UMLS:C5785351

object_name: HER2 positive breast carcinoma


subject: UMLS:C5785351

object_name: Metastatic gastric adenocarcinoma


subject: UMLS:C5785351

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: PUBCHEM.COMPOUND:11842633

subject_name: velusetrag

object_name: Alzheimer disease


subject: UNII:J4VNV64ARB

subject_name: Velusetrag


subject: UMLS:C5400018

subject_name: Defibrotide, Pig

object_name: Sinusoidal Obstruction Syndrome, CTCAE


subject: UNII:438HCF2X0M

subject_name: Defibrotide


subject: GTOPDB:7986

subject_name: rilotumumab

object_name: Recurrent Primary Peritoneal Carcinoma


subject: GTOPDB:7986

object_name: Recurrent ovarian cancer


subject: GTOPDB:7986

object_name: Recurrent Fallopian Tube Carcinoma


subject: UNII:51WEW898IJ


subject: UNII:51WEW898IJ


subject: UNII:51WEW898IJ


subject: UMLS:C1879711

subject_name: AMG 102


subject: UMLS:C1879711


subject: UMLS:C1879711


subject: CHEBI:35745

object_name: diphtheria


subject: CHEBI:35745

object_name: tetanus


subject: CHEBI:35739

subject_name: Pentetic acid


subject: CHEBI:35739


subject: CHEBI:74854

subject_name: Thr-Asp


subject: CHEBI:74854


subject: UMLS:C0305060

subject_name: Tetanus and diphtheria toxoid adsorbed for adult use


subject: UMLS:C0305060


subject: MESH:D011054

subject_name: Poliovirus Vaccine, Inactivated


subject: MESH:D011054


subject: UMLS:C5241183

subject_name: Vaccine product containing only inactivated whole Human poliovirus antigen (medicinal product)


subject: UMLS:C5241183


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: cholangiocarcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0006669

subject_name: Calcitonin Gene-Related Peptide

object_name: Common Migraine


subject: PR:000014405

subject_name: protein S100-A12


subject: CHEBI:7627

subject_name: Norethisterone

object_name: blood coagulation disease


subject: CHEBI:63624

subject_name: Telbivudine

object_name: Chronic viral hepatitis B without delta-agent


subject: UMLS:C1958570

object_name: hypertension


subject: UMLS:C1958570

object_name: Hypertension, CTCAE


subject: UMLS:C0947677

subject_name: Lipiodol

object_name: female infertility


subject: CHEBI:50692

subject_name: Mifepristone

object_name: Diabetes


subject: CHEBI:50692

object_name: diabetes mellitus


subject: CHEBI:50692

object_name: endocrine system disorder


subject: CHEBI:188719

subject_name: Ertugliflozin

object_name: Heart failure with reduced ejection fraction


subject: CHEBI:188719

object_name: Heart failure with mid range ejection fraction


subject: CHEBI:24848

subject_name: inositol


subject: CHEBI:27470

subject_name: Folic acid


subject: UNII:3P63ZTE3OY

subject_name: Seralutinib

object_name: pulmonary hypertension, primary, 1


subject: UNII:3P63ZTE3OY

object_name: idiopathic pulmonary arterial hypertension


subject: UNII:3P63ZTE3OY

object_name: pulmonary arterial hypertension


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Infection


subject: CHEBI:100241

object_name: Adverse Event Associated with Infection


subject: PUBCHEM.COMPOUND:3298

subject_name: Eicosapentaenoic acid ethyl ester

object_name: Huntington disease


subject: UMLS:C1565135

subject_name: Ethyl-EPA


subject: CHEBI:84883

subject_name: Icosapent ethyl


subject: CHEBI:125354

subject_name: Plerixafor

object_name: Myelokathexis


subject: CHEBI:125354

object_name: common wart


subject: CHEBI:125354

object_name: leukopenia


subject: CHEBI:125354

object_name: neutropenia


subject: CHEBI:125354


subject: CHEBI:125354

object_name: Infection of musculoskeletal system


subject: CHEBI:33380

subject_name: thulium atom


subject: CHEBI:33380


subject: CHEBI:33380


subject: CHEBI:33380


subject: CHEBI:33380


subject: CHEBI:33380


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:74861


subject: CHEBI:74861


subject: CHEBI:74861


subject: CHEBI:74861


subject: CHEBI:74861


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:55460


subject: CHEBI:55460


subject: CHEBI:55460


subject: CHEBI:55460


subject: CHEBI:55460


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: CHEBI:30703


subject: CHEBI:30703


subject: CHEBI:30703


subject: CHEBI:30703


subject: CHEBI:30703


subject: UMLS:C3166394

subject_name: Tm antigen


subject: UMLS:C3166394


subject: UMLS:C3166394


subject: UMLS:C3166394


subject: UMLS:C3166394


subject: UMLS:C3166394


subject: PR:000002105

subject_name: thrombomodulin


subject: PR:000002105


subject: PR:000002105


subject: PR:000002105


subject: PR:000002105


subject: PR:000002105


subject: CHEBI:75045

subject_name: Dabrafenib

object_name: Metastatic Thyroid Gland Carcinoma


subject: CHEBI:75045

object_name: Unresectable Thyroid Gland Carcinoma


subject: CHEBI:49603

subject_name: Lapatinib


subject: CHEBI:49603


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Hypothermia due to exposure


subject: CHEBI:119915

object_name: Hypothermia


subject: CHEBI:119915

object_name: Hypothermia, CTCAE


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: CHEBI:6931


subject: CHEBI:8802

subject_name: Remifentanil


subject: CHEBI:8802


subject: CHEBI:8802


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:76018

subject_name: Riociguat

object_name: scleroderma


subject: CHEBI:76018

object_name: Digital ulcer


subject: UNII:FBK9G669EY

subject_name: CHO CELL


subject: CHEBI:8378

subject_name: Prednisolone

object_name: facial nerve disorder


subject: CHEBI:8378

object_name: Borrelia infection of central nervous system


subject: UMLS:C0218182

subject_name: Recombinate

object_name: hemophilia A


subject: UMLS:C1815367

subject_name: Helixate FS


subject: UMLS:C1831890

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C1831890

object_name: Ovarian cancer stage IV


subject: UMLS:C1831890

object_name: malignant neoplasm of ovary stage IV


subject: UMLS:C1831890

object_name: malignant neoplasm of ovary stage IIIc


subject: UMLS:C1831890

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: DRUGBANK:DB16615

subject_name: Krill oil

object_name: Obesity associated disorder


subject: PUBCHEM.COMPOUND:139350422

subject_name: Zanzalintinib

object_name: Aggressive Variant Prostate Carcinoma


subject: UNII:KC2JC2ZA04

subject_name: ZANZALINTINIB


subject: UNII:MJ4PTD2VVW

subject_name: GALANTAMINE HYDROBROMIDE

object_name: Pick Complex


subject: UNII:MJ4PTD2VVW

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: UNII:MJ4PTD2VVW

object_name: frontotemporal dementia


subject: UNII:MJ4PTD2VVW

object_name: Pick disease


subject: CHEBI:42944

subject_name: Galantamine


subject: CHEBI:42944


subject: CHEBI:42944


subject: CHEBI:42944


subject: UMLS:C5222462

subject_name: Liraglutide Injection

object_name: Emergence Delirium


subject: CHEBI:16831

subject_name: Meglutol

object_name: infertility


subject: UMLS:C0178700

subject_name: hydroxymethylglutarate


subject: PUBCHEM.COMPOUND:9904258

object_name: bipolar I disorder


subject: CHEBI:174358

subject_name: Eslicarbazepine


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: High-Risk Cancer


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: Pleural Infection


subject: PUBCHEM.COMPOUND:22976653

object_name: Pleural Infection, CTCAE


subject: PUBCHEM.COMPOUND:22976653

object_name: Pleural effusion associated with pulmonary infection


subject: PUBCHEM.COMPOUND:22976653

object_name: pleural empyema


subject: PUBCHEM.COMPOUND:22976653

object_name: empyema


subject: PUBCHEM.COMPOUND:22976653

object_name: pleural disease


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: UNII:1RXS4UE564


subject: UNII:1RXS4UE564


subject: UNII:1RXS4UE564


subject: UNII:1RXS4UE564


subject: UNII:1RXS4UE564


subject: CHEBI:37537

subject_name: Phorbol 12-myristate 13-acetate diester


subject: CHEBI:37537


subject: CHEBI:37537


subject: CHEBI:37537


subject: CHEBI:37537


subject: CHEBI:37537


subject: CHEBI:15702


subject: CHEBI:15702


subject: CHEBI:15702


subject: CHEBI:15702


subject: CHEBI:15702


subject: CHEBI:15702


subject: CHEBI:53394

subject_name: phosphotungstic acid macromolecule


subject: CHEBI:53394


subject: CHEBI:53394


subject: CHEBI:53394


subject: CHEBI:53394


subject: CHEBI:53394


subject: CHEBI:61432

subject_name: phosphotungstic acid polymer


subject: CHEBI:61432


subject: CHEBI:61432


subject: CHEBI:61432


subject: CHEBI:61432


subject: CHEBI:61432


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: PR:000012825


subject: PR:000012825


subject: PR:000012825


subject: PR:000012825


subject: PR:000012825


subject: UMLS:C0011519

subject_name: Deoxyribonuclease I


subject: UMLS:C0011519


subject: UMLS:C0011519


subject: UMLS:C0011519


subject: UMLS:C0011519


subject: UMLS:C0011519


subject: UMLS:C0011522

subject_name: deoxyribonucleases


subject: UMLS:C0011522


subject: UMLS:C0011522


subject: UMLS:C0011522


subject: UMLS:C0011522


subject: UMLS:C0011522


subject: CHEBI:74705

subject_name: Met-Leu

object_name: xerophthalmia


subject: CHEBI:74705

object_name: Dry Eye Syndrome, CTCAE


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: CHEMBL.COMPOUND:CHEMBL2108661

subject_name: VEHICLE


subject: CHEMBL.COMPOUND:CHEMBL2108661

object_name: dry eye syndrome


subject: CHEMBL.COMPOUND:CHEMBL2108661


subject: UMLS:C5671028

object_name: Wet age-related macular degeneration


subject: UMLS:C5671028

object_name: wet macular degeneration


subject: PUBCHEM.COMPOUND:74895541

subject_name: DOXEPIN HYDROCHLORIDE

object_name: mucositis


subject: PUBCHEM.COMPOUND:74895541

object_name: Neck Carcinoma


subject: PUBCHEM.COMPOUND:74895541

object_name: head and neck neoplasm


subject: PUBCHEM.COMPOUND:74895541

object_name: head and neck cancer


subject: PUBCHEM.COMPOUND:74895541

object_name: Oral Complication of Radiation Therapy


subject: UNII:3U9A0FE9N5


subject: UNII:3U9A0FE9N5


subject: UNII:3U9A0FE9N5


subject: UNII:3U9A0FE9N5


subject: UNII:3U9A0FE9N5


subject: CHEBI:4710

subject_name: Doxepin


subject: CHEBI:4710


subject: CHEBI:4710


subject: CHEBI:4710


subject: CHEBI:4710


subject: CHEBI:9014

subject_name: Salsalate

object_name: Vascular Stiffness


subject: CHEBI:9014

object_name: Diastolic dysfunction


subject: UMLS:C3540795

subject_name: ENDOCRINE THERAPY ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

object_name: Pathology processes


subject: CHEBI:81570

subject_name: Chorionic Gonadotropin (Human)

object_name: X-linked congenital generalized hypertrichosis


subject: UMLS:C0309130

subject_name: Follutein


subject: UMLS:C1141639

subject_name: human chorionic gonadotropin


subject: UNII:98BSN6N516

subject_name: Rogaratinib

object_name: bladder tumor


subject: UNII:98BSN6N516

object_name: urinary bladder carcinoma


subject: UNII:98BSN6N516

object_name: urinary bladder cancer


subject: UNII:98BSN6N516

object_name: childhood bladder carcinoma


subject: UMLS:C3827091

object_name: chronic hepatitis C virus infection


subject: UNII:3096O7WP53

object_name: chronic pain (diagnosis)


subject: UNII:3096O7WP53

object_name: Chronic pain


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: bronchiectasis


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C5555141

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C5555141

object_name: mantle cell lymphoma


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: large B-cell lymphoma


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:40968

subject_name: Astaxanthin

object_name: male infertility


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEBI:8988

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:8988

object_name: peritoneal carcinoma


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: Metastatic Renal Cell Carcinoma


subject: UNII:5S371K6132

object_name: Metastatic Renal Cell Cancer


subject: PR:000002105

subject_name: thrombomodulin

object_name: glioblastoma


subject: PR:000002105

object_name: Childhood Glioblastoma


subject: PR:000002105

object_name: adult glioblastoma


subject: UMLS:C0006051

object_name: Drooling


subject: UNII:Q46947FE7K

subject_name: Peginterferon alfa-2a

object_name: Liver Fibrosis


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:63717

subject_name: Tenofovir disoproxil


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:175964

subject_name: beta-Bixin

object_name: arteriosclerosis disorder


subject: CHEBI:175964

object_name: atherosclerosis


subject: CHEBI:175964

object_name: Increased reactive oxygen species production


subject: CHEBI:3136

subject_name: bixin


subject: CHEBI:3136


subject: CHEBI:3136


subject: PUBCHEM.COMPOUND:92801

subject_name: Norbixin


subject: PUBCHEM.COMPOUND:92801


subject: PUBCHEM.COMPOUND:92801


subject: CHEBI:16581

subject_name: Pregnenolone

object_name: Menopause present (finding)


subject: CHEBI:16581

object_name: Menopause


subject: UMLS:C5235865

object_name: Childhood Solid Neoplasm


subject: UMLS:C5235865

object_name: Adult Solid Neoplasm


subject: UMLS:C5235865

object_name: Solid Neoplasm


subject: UMLS:C5235865

object_name: adult lymphoma


subject: UMLS:C5235865

object_name: lymphoma


subject: UMLS:C5235865

object_name: pediatric lymphoma


subject: CHEBI:5118

subject_name: Fluoxetine

object_name: Domestic Violence


subject: CHEBI:5118

object_name: domestic violence at home (history)


subject: RXCUI:1989496

subject_name: dolutegravir / rilpivirine Oral Product

object_name: HIV infection


subject: CHEBI:31646

subject_name: Gefarnate

object_name: coronary artery disorder


subject: CHEBI:31646

object_name: coronary atherosclerosis


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: cardiogenic shock


subject: CHEBI:188074

object_name: chronic hepatitis C virus infection


subject: CHEBI:188074

object_name: Fatty Liver


subject: CHEBI:50122

subject_name: Rosiglitazone


subject: CHEBI:50122


subject: UNII:Q46947FE7K


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: UMLS:C2984025

subject_name: Ferinject

object_name: acute myocardial infarction


subject: UMLS:C2984025

object_name: Acute Myocardial Infarction by ECG Finding


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Adult Rhabdomyosarcoma


subject: UNII:PQX0D8J21J

object_name: rhabdomyosarcoma


subject: UNII:PQX0D8J21J

object_name: Childhood Rhabdomyosarcoma


subject: UNII:PQX0D8J21J

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:3139

subject_name: bleomycin

object_name: head and neck cancer


subject: UMLS:C1963644

subject_name: Talc dusting powder

object_name: Secondary spontaneous pneumothorax


subject: UMLS:C5439002

subject_name: Influenza A virus subtype H5N1 antigen only vaccine product

object_name: avian influenza


subject: DRUGBANK:DB17362

subject_name: Obecabtagene autoleucel

object_name: chronic progressive multiple sclerosis


subject: PUBCHEM.COMPOUND:22064497

subject_name: Elagolix

object_name: Unexplained infertility


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: peroxisome biogenesis disorder


subject: CHEBI:5801

object_name: Zellweger spectrum disorders


subject: CHEBI:177770

subject_name: Ganetespib

object_name: HER2 positive breast carcinoma


subject: CHEBI:177770

object_name: male breast carcinoma


subject: CHEBI:177770

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:177770

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:177770

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:177770

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:177770

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:177770

object_name: Carcinoma breast stage IV


subject: CHEBI:177770

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:177770

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:177770

object_name: Breast cancer recurrent


subject: CHEBI:177770

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:177770

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:177770

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:177770

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:177770

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:177770

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:K16AIQ8CTM

subject_name: Pertuzumab


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: UNII:K16AIQ8CTM


subject: CHEBI:135720

subject_name: Deflazacort

object_name: autosomal recessive limb-girdle muscular dystrophy type 2B


subject: CHEBI:135720

object_name: Dysferlinopathy


subject: CHEBI:135720

object_name: Miyoshi myopathy


subject: CHEBI:135720

object_name: Miyoshi muscular dystrophy 1


subject: CHEBI:167450

subject_name: Monomethyl fumarate

object_name: multiple sclerosis


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: Non-insulin-dependent diabetes mellitus without complications


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin


subject: CHEBI:76016

subject_name: Vortioxetine

object_name: post-traumatic stress disorder


subject: UNII:2CN60TN6ZS

subject_name: Lurbinectedin

object_name: Ewing sarcoma


subject: UNII:2CN60TN6ZS

object_name: undifferentiated embryonal sarcoma of the liver


subject: UNII:2CN60TN6ZS

object_name: undifferentiated sarcoma of soft tissue


subject: UNII:2CN60TN6ZS

object_name: undifferentiated (embryonal) sarcoma


subject: UNII:2CN60TN6ZS

object_name: Anaplastic sarcoma


subject: UNII:2CN60TN6ZS

object_name: Childhood Desmoplastic Small Round Cell Tumor


subject: UNII:2CN60TN6ZS

object_name: desmoplastic small round cell tumor


subject: UNII:2CN60TN6ZS

object_name: Adult Desmoplastic Small Round Cell Tumor


subject: UNII:2CN60TN6ZS

object_name: childhood malignant neoplasm


subject: GTOPDB:10656

subject_name: ianalumab

object_name: autoimmune thrombocytopenia


subject: UNII:ZN2GQ3II96


subject: UMLS:C3896750


subject: DRUGBANK:DB17781

object_name: Mononegavirales infectious disease


subject: DRUGBANK:DB17781

object_name: Filoviridae infectious disease


subject: DRUGBANK:DB17781

object_name: viral hemorrhagic fever


subject: DRUGBANK:DB17781

object_name: RNA Virus Infections


subject: DRUGBANK:DB17781

object_name: viral disease


subject: DRUGBANK:DB17781

object_name: Infection


subject: DRUGBANK:DB17781

object_name: Infection of musculoskeletal system


subject: UMLS:C5815621


subject: UMLS:C5815621


subject: UMLS:C5815621


subject: UMLS:C5815621


subject: UMLS:C5815621


subject: UMLS:C5815621


subject: UMLS:C5815621


subject: UMLS:C5815505


subject: UMLS:C5815505


subject: UMLS:C5815505

object_name: Ebola hemorrhagic fever


subject: UMLS:C5815505


subject: UMLS:C5815505


subject: UMLS:C5815505


subject: UMLS:C5815505


subject: UMLS:C5815505


subject: UMLS:C5815589

subject_name: MVA-BN Filo


subject: UMLS:C5815589


subject: UMLS:C5815589


subject: UMLS:C5815589


subject: UMLS:C5815589


subject: UMLS:C5815589


subject: UMLS:C5815589


subject: UMLS:C5815589


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Stress


subject: CHEBI:3723

subject_name: Citalopram


subject: MESH:D056692

subject_name: Prebiotics

object_name: peanut allergy


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: glucocorticoid resistance


subject: CHEBI:6888

object_name: neuromyelitis optica


subject: CHEBI:6888

object_name: Gross Extranodal Extension


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: renal pelvis/ureter urothelial carcinoma


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C0718247

subject_name: Active brand of pseudoephedrine-triprolidine

object_name: Overweight and obesity


subject: UMLS:C2984036

object_name: Solid Neoplasm


subject: UNII:P0GVQ9A4S5

subject_name: Dostarlimab

object_name: Stage III Cutaneous Melanoma AJCC v6


subject: UNII:P0GVQ9A4S5

object_name: metastatic melanoma


subject: UMLS:C4287697


subject: UMLS:C4287697


subject: CHEBI:95021

subject_name: pemetrexed

object_name: Childhood Solid Neoplasm


subject: UNII:8GZG754X6M

subject_name: Gemtuzumab

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UNII:8GZG754X6M

object_name: Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome


subject: UMLS:C0677800

subject_name: CMA 676


subject: UMLS:C0677800


subject: UMLS:C5399992


subject: UMLS:C5399992


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Anterior Cruciate Ligament Injuries


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib

object_name: High Grade B-Cell Lymphoma, Not Otherwise Specified


subject: UNII:AG9MHG098Z

object_name: high grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement


subject: CHEBI:9123

subject_name: Sertraline

object_name: chronic kidney disease


subject: CHEBI:9123

object_name: Chronic Kidney Disease, CTCAE


subject: CHEBI:145371

subject_name: Binimetinib

object_name: neurofibromatosis 1


subject: CHEBI:145371

object_name: neurofibromatosis type 1


subject: CHEBI:145371

object_name: plexiform neurofibroma


subject: UMLS:C3267707

subject_name: amphetamine mixed salts

object_name: attention deficit hyperactivity disorder, inattentive type


subject: UMLS:C3267707


subject: UMLS:C1170024

subject_name: Adderall-XR


subject: UMLS:C1170024


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: congestive heart failure


subject: PUBCHEM.COMPOUND:2735

object_name: cardiomyopathy


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: PUBCHEM.COMPOUND:10883523


subject: UMLS:C3265062


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: UNII:1C6V77QF41


subject: UMLS:C4730830

subject_name: Timolol Maleate Ophthalmic Solution

object_name: open-angle glaucoma


subject: UMLS:C4730830

object_name: ocular hypertension


subject: UMLS:C4730830

object_name: Ocular hypertension


subject: CHEBI:25255

subject_name: methyl methanesulfonate

object_name: anemia


subject: CHEBI:25255

object_name: Anemia, CTCAE


subject: CHEBI:91400

subject_name: Afatinib

object_name: gallbladder carcinoma


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: Chronic small plaque psoriasis


subject: UNII:089658A12D

object_name: guttate psoriasis


subject: PUBCHEM.COMPOUND:11306691

subject_name: rac-Sitagliptin

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:40237

subject_name: Sitagliptin


subject: CHEBI:291342

subject_name: Desloratadine

object_name: atopic conjunctivitis


subject: UMLS:C0498915

subject_name: INJECTION, LEUPROLIDE ACETATE (FOR DEPOT SUSPENSION), PER 3.75 MG ADMINISTERED

object_name: Maternity blues


subject: UMLS:C0498915

object_name: perinatal asphyxia


subject: UMLS:C0498915

object_name: Perinatal depression in mother


subject: UMLS:C0498915

object_name: Depressed mood


subject: UMLS:C0498915

object_name: Cancer patients and suicide and depression


subject: UMLS:C0498915

object_name: Depressed - symptom


subject: UMLS:C0498915

object_name: Depression, CTCAE


subject: CHEBI:74705

subject_name: Met-Leu


subject: CHEBI:74705


subject: CHEBI:74705


subject: CHEBI:74705


subject: CHEBI:74705


subject: CHEBI:74705


subject: CHEBI:74705


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:17026


subject: CHEBI:17026


subject: CHEBI:17026


subject: CHEBI:17026


subject: CHEBI:17026


subject: CHEBI:17026


subject: UMLS:C1314420

subject_name: INJECTION, RASBURICASE, 0.5 MG ADMINISTERED

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C1314420

object_name: metabolic syndrome X


subject: UMLS:C1314420

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C1314420

object_name: obesity


subject: UMLS:C1314420

object_name: Obesity, CTCAE


subject: UNII:08GY9K1EUO

subject_name: Rasburicase


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UNII:08GY9K1EUO


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: CHEBI:109549

subject_name: Ramelteon

object_name: nicotine dependence


subject: UNII:971Z4W1S09

subject_name: Technetium Tc-99m sestamibi

object_name: mucocutaneous lymph node syndrome


subject: CHEBI:33353

subject_name: technetium atom


subject: UMLS:C2012940

subject_name: tetrahydrocannabinol (medication)

object_name: osteoarthritis, knee


subject: CHEBI:25805

subject_name: oxygen atom

object_name: lumbar spinal stenosis


subject: CHEBI:25805

object_name: spinal stenosis


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: myelofibrosis


subject: UNII:6XC1PAD3KF

object_name: Myeloid Metaplasia


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: UNII:834YJF89WO

subject_name: Belumosudil

object_name: Lung transplant rejection


subject: UNII:F5Z5EL4D26

subject_name: Lonaprisan

object_name: Carcinoma breast stage IV


subject: UMLS:C0963633


subject: UMLS:C4721716


subject: CHEMBL.COMPOUND:CHEMBL3833369

subject_name: FISH OIL

object_name: breast fibrocystic disease


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: head and neck squamous cell carcinoma


subject: CHEBI:73604

object_name: metastatic malignant neoplasm in the lymph nodes


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Rasmussen subacute encephalitis


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Stomach cancer


subject: CHEBI:4466

object_name: gastric cancer


subject: CHEBI:4466

object_name: Gastrostomy site


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: CHEBI:78739

subject_name: Emodepside

object_name: trichuriasis


subject: UMLS:C1098962


subject: UMLS:C0085826

subject_name: Antiplatelet Agents

object_name: Serum uric acid result


subject: CHEBI:87631

subject_name: statin


subject: CHEBI:35674

subject_name: antihypertensive agent


subject: UMLS:C0003364

subject_name: Antihypertensive Agents


subject: CHEBI:93274

subject_name: Fluvoxamine

object_name: endogenous depression


subject: CHEBI:93274

object_name: major depressive disorder


subject: CHEBI:76018

subject_name: Riociguat

object_name: Pulmonary vascular disorder


subject: CHEBI:76018

object_name: primary pulmonary hypertension


subject: CHEBI:76018

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:76018

object_name: Other systemic involvement of connective tissue


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: primary ciliary dyskinesia


subject: CHEBI:33357

subject_name: hassium atom


subject: CHEBI:74056

subject_name: His-Ser


subject: UMLS:C0021031

subject_name: Fab Immunoglobulins

object_name: liver cancer


subject: UMLS:C3714111

object_name: Human papillomavirus infection in conditions classified elsewhere and of unspecified site


subject: CHEBI:91951

object_name: invasive ductal breast carcinoma


subject: CHEBI:91951

object_name: breast ductal adenocarcinoma


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:17756771